BUY Nestle India Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)17 Oct 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·6 May · 2d ago
Nestle India Limited has set July 10, 2026, as the record date for its final dividend payment.
NSE · Record Date·21 Apr · 2w ago
Nestle India Ltd approved audited financial results for FY26, recommended a final dividend, and announced the 67th AGM date.
BSE · Board Meeting·21 Apr · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Nestle India
- BUY — Axis Securities16 Oct 2026 · ~1 year · target ₹1,470 · Active
- BUY — BOB Capital Markets16 Oct 2026 · ~1 year · target ₹1,755 · Active
- BUY — ICICI Securities16 Oct 2026 · ~1 year · target ₹1,600 · Active
- BUY — Elara Capital16 Oct 2026 · ~1 year · target ₹1,506 · Active
- BUY — Ashish Bahety, Profitmart Securities15 Oct 2026 · Same day · target ₹1,420 · SL hit
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

